ProteoMediX

ProteoMediX

ProteoMediX

ProteoMediX is a spinoff company of ETH Zurich and specialized in theidentification of novel biomarkers for the early detection of cancer
Founded
2010
Raised
$8.3M
Follow us
Alexa global traffic share
Latest funding
€4,500,000
Venture capital (Series C) - 2016
Altos Venture Zürcher Kantonalbank
$3,345,160
Venture capital (Series B) - 2014
Team Size
2
Employees
€4,500,000 Venture capital (Series C)
FinSMEs

ProteoMediX Raises CHF5M in Financing Round

Health Funding